A detailed history of Envestnet Portfolio Solutions, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Envestnet Portfolio Solutions, Inc. holds 19,493 shares of EXAS stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,493
Previous 19,789 1.5%
Holding current value
$1.29 Million
Previous $1.37 Million 39.75%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$41.33 - $74.26 $12,233 - $21,980
-296 Reduced 1.5%
19,493 $823,000
Q1 2024

May 06, 2024

SELL
$56.27 - $73.77 $119,855 - $157,130
-2,130 Reduced 9.72%
19,789 $1.37 Million
Q4 2023

Feb 07, 2024

BUY
$59.06 - $75.72 $70,872 - $90,864
1,200 Added 5.79%
21,919 $1.62 Million
Q3 2023

Nov 13, 2023

BUY
$65.94 - $99.04 $1.37 Million - $2.05 Million
20,719 New
20,719 $1.41 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.7B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Envestnet Portfolio Solutions, Inc. Portfolio

Follow Envestnet Portfolio Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Portfolio Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Portfolio Solutions, Inc. with notifications on news.